Literature DB >> 20064547

Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

Malin von Otter1, Sara Landgren, Staffan Nilsson, Madeleine Zetterberg, Dragana Celojevic, Petra Bergström, Lennart Minthon, Nenad Bogdanovic, Niels Andreasen, Deborah R Gustafson, Ingmar Skoog, Anders Wallin, Gunnar Tasa, Kaj Blennow, Michael Nilsson, Ola Hammarsten, Henrik Zetterberg.   

Abstract

Alzheimer's disease (AD) and age-related cataract, disorders characterized by protein aggregation causing late-onset disease, both involve oxidative stress. We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract. This case-control study combines an AD material (725 cases and 845 controls), and a cataract material (489 cases and 182 controls). Genetic variation in NFE2L2 and KEAP1 was tagged by eight and three tag single nucleotide polymorphisms (SNPs), respectively. Single SNPs and haplotypes were analyzed for associations with disease risk, age parameters, MMSE and AD cerebrospinal fluid biomarkers. NFE2L2 and KEAP1 were not associated with risk of AD or cataract. However, one haplotype allele of NFE2L2 was associated with 2 years earlier age at AD onset (p(c)=0.013) and 4 years earlier age at surgery for posterior subcapsular cataract (p(c)=0.019). Another haplotype of NFE2L2 was associated with 4 years later age at surgery for cortical cataract (p(c)=0.009). Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract. However, common variants of the NFE2L2 gene may affect disease progression, potentially altering clinically recognized disease onset. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064547     DOI: 10.1016/j.mad.2009.12.007

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  37 in total

1.  A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease.

Authors:  Sara Landgren; Malin von Otter; Mona Seibt Palmér; Caroline Zetterström; Staffan Nilsson; Ingmar Skoog; Deborah R Gustafson; Lennart Minthon; Anders Wallin; Niels Andreasen; Nenad Bogdanovic; Jan Marcusson; Kaj Blennow; Henrik Zetterberg; Petronella Kettunen
Journal:  J Neural Transm (Vienna)       Date:  2012-05-25       Impact factor: 3.575

2.  RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.

Authors:  Nadine Bakkar; Arianna Kousari; Tina Kovalik; Yang Li; Robert Bowser
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

3.  Sustained Effects of Neonatal Systemic Lipopolysaccharide on IL-1β and Nrf2 in Adult Rat Substantia Nigra Are Partly Normalized by a Spirulina-Enriched Diet.

Authors:  Jaspal Patil; Ashok Matte; Hans Nissbrandt; Carina Mallard; Mats Sandberg
Journal:  Neuroimmunomodulation       Date:  2016-12-09       Impact factor: 2.492

Review 4.  Caenorhabditis elegans as a model organism to study APP function.

Authors:  Collin Y Ewald; Chris Li
Journal:  Exp Brain Res       Date:  2011-10-29       Impact factor: 1.972

5.  No association of LOXL1 gene polymorphisms with Alzheimer's disease.

Authors:  Alexandra Abramsson; Sara Landgren; Madeleine Zetterberg; Mona Seibt Palmer; Lennart Minthon; Deborah R Gustafson; Ingmar Skoog; Kaj Blennow; Henrik Zetterberg
Journal:  Neuromolecular Med       Date:  2011-05-11       Impact factor: 3.843

Review 6.  Functional polymorphisms in Nrf2: implications for human disease.

Authors:  Hye-Youn Cho; Jacqui Marzec; Steven R Kleeberger
Journal:  Free Radic Biol Med       Date:  2015-06-25       Impact factor: 7.376

Review 7.  Epigenetic regulation of Keap1-Nrf2 signaling.

Authors:  Yue Guo; Siwang Yu; Chengyue Zhang; Ah-Ng Tony Kong
Journal:  Free Radic Biol Med       Date:  2015-06-25       Impact factor: 7.376

Review 8.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

9.  Association of the RAGE G82S polymorphism with Alzheimer's disease.

Authors:  Jonny Daborg; Malin von Otter; Annica Sjölander; Staffan Nilsson; Lennart Minthon; Deborah R Gustafson; Ingmar Skoog; Kaj Blennow; Henrik Zetterberg
Journal:  J Neural Transm (Vienna)       Date:  2010-06-22       Impact factor: 3.575

Review 10.  NRF2-regulation in brain health and disease: implication of cerebral inflammation.

Authors:  Mats Sandberg; Jaspal Patil; Barbara D'Angelo; Stephen G Weber; Carina Mallard
Journal:  Neuropharmacology       Date:  2013-11-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.